Navigation Links
Laureate Pharma Changes Name to Laureate Biopharmaceutical Services, Inc.
Date:1/31/2011

PRINCETON, N.J., Jan. 31, 2011 /PRNewswire/ -- Laureate Pharma, Inc. has changed its name to Laureate Biopharmaceutical Services, Inc. (Laureate Biopharma) to better describe the company's positioning in the biopharmaceutical industry.  The company's logo has been updated to emphasize "Laureate" and to incorporate a laurel wreath, illustrating Laureate Biopharma's reputation for scientific excellence and commitment to delivery.  In addition, the company has established a new homepage (www.lbios.com).  

Laureate Biopharma has been in continuous operation in its Princeton, New Jersey facility since 1981.  Since 1996, Laureate Biopharma has focused exclusively on serving other developers in the biotherapeutics market.  

"We are building on Laureate Biopharma's rich history and adding technologies, capacity and staff, while extending our reputation for quality and delivery," said Michael A. Griffith, Chief Executive Officer.  "This name change, although subtle, speaks to our wealth of experience in protein production and a deep scientific bench, which is unique to the industry."

This name change follows the company's announcement of $20 million in secured capital.  All strategically planned improvements are continuing as previously announced.  These include:

  • Adoption of new quality systems technologies
  • Upgrade of aseptic fill capabilities
  • Upgrade and expansion of protein production facilities and services
  • Expansion of mammalian cell line creation services, and
  • Launch of a contract analytical testing business

For more information related to Laureate Biopharma's capabilities and ongoing improvements please visit them at their new website, www.lbios.com.  

About Laureate Biopharmaceutical Services, Inc.

Laureate Biopharmaceutical Services, Inc. is a full-service biopharmaceutical contract development and manufacturing organization. Laureate Biopharma's scientists are expert in process development and cGMP production of therapeutic proteins including monoclonal antibodies and Fc-fusion proteins. In addition, the company's portfolio of services includes aseptic filling, cell line development, analytical and stability testing, and regulatory support. Laureate Biopharma has served a global client base from its Princeton, New Jersey facility since 1981 and is a portfolio company of Saints Capital, LLC.  For more information, please visit www.lbios.com.

About Saints Capital, LLC

Saints Capital is a leading direct secondary acquirer of venture capital and private equity investments in emerging growth companies around the globe. It also makes traditional direct venture capital investments on a primary basis and in special situations in technology, healthcare, consumer and industrial companies in the United States. Founded in 2000, Saints provides liquidity for private investors in such markets as investment and commercial banks, buyouts, corporate venture capital and hedge funds. Saints has more than $1 billion of committed capital under management, over 50 completed portfolio transactions and investments in more than 200 companies. For more information, please visit www.saintsvc.com.

For more information, contact: Imara Charles, Ph.D., Director of Project Management, Laureate Biopharmaceutical Services, at (609) 919-3367, or info@lbios.com or visit www.lbios.com or Jennifer Vollaro at Integrated Marketing Services at (609) 683.9055 ext. 247, or jvollaro@imsworld.com


'/>"/>
SOURCE Laureate Biopharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
2. Laureate Pharma Announces New Development and Manufacturing Agreement to Produce AVEO Pharmaceuticals Antibody Therapeutic
3. Elsevier Celebrates Nine 2010 Nobel Laureates and Honors Achievements With Freely Available Prize-Winning Research
4. Laureate Pharma Secures $20 Million to Enhance and Grow Biopharmaceutical Contract Manufacturing Business
5. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
6. Thomson Reuters Predicts Nobel Laureates
7. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
8. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
9. Vanda Pharmaceuticals Files Shelf Registration Statement
10. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
11. Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for ... Vincent J. Angotti has been appointed ... company,s board of directors, effective Monday, March 6, ... experience leading executive and commercial teams at public ...
(Date:2/16/2017)... , Feb. 16, 2017  Prescription pain medications ... department visit are necessary for long-term opioid use to ... Feb. 16 th edition of The New ... "Emergency physicians see more patients in acute pain than ... Parker , MD, FACEP, president of the American College ...
(Date:2/16/2017)... Research and Markets has announced the addition of the ... Function, Application, Cancer Type, Technology - Forecast to 2025" report ... ... grow at a CAGR of around 28.6% over the next decade ... Some of the prominent trends that the market is witnessing include ...
Breaking Medicine Technology:
(Date:2/18/2017)... ... February 17, 2017 , ... Focused ... innovation in the industry, according to the recent NEJM Catalyst Insights Report on ... of the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical ...
(Date:2/18/2017)... ... 2017 , ... A new directory from the Senior Veterans ... connect elderly veterans of America's armed forces to a range of senior care ... on this year's increase in the Veterans Pension with Aid & Attendance for ...
(Date:2/17/2017)... ... 2017 , ... For the first time, International Scholarship and ... floor for the 2017 HIMSS Conference & Exhibition at the Orange ... than 40,000 healthcare industry professionals are expected at the conference, where they will ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access today ... Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will ... used electronic patient signatures solution in healthcare . , Since it first ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer diagnostics workflow solution provider ... 20 – 22 in San Francisco. As part of the Tri-Conference expo, which ... workflow solution, as well as its new precision medicine platform, “Crosswalk Insight: Oncology™.” ...
Breaking Medicine News(10 mins):